Nicholas Galakatos insider trades: Entasis Therapeutics Holdings (ETTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nicholas reports to the SEC
and 32 more companies
Open-market buys and sales
104 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 28, 2018 | ETTX | ↑ Buy | 453,395 | $15.00 | $6.8M | Indirect | Oct 2, 2018 (4d) |
| Sep 17, 2018 | NSTG | ↓ Sell | 85,823 | $15.99 | $1.4M | Indirect | Sep 19, 2018 (2d) |
| Jul 2, 2018 | FTSV | ↑ Buy | 200,000 | $16.00 | $3.2M | Indirect | Jul 2, 2018 (0d) |
| Feb 9, 2016 | TLOG | ↓ Sell | 333,630 | $0.17 | $56K | Direct | Feb 10, 2016 (1d) |
| Feb 5, 2016 | TLOG | ↓ Sell | 1,415,490 | $0.18 | $249K | Direct | Feb 5, 2016 (0d) |
| Feb 2, 2016 | TLOG | ↓ Sell | 369,132 | $0.19 | $72K | Direct | Feb 2, 2016 (0d) |
| Jan 28, 2016 | TLOG | ↓ Sell | 311,930 | $0.28 | $86K | Direct | Jan 28, 2016 (0d) |
| Jan 11, 2016 | OPHT | ↓ Sell | 2,000 | $65.89 | $132K | Direct | Jan 13, 2016 (2d) |
| Jan 11, 2016 | OPHT | ↓ Sell | 1,000 | $65.39 | $65K | Indirect | Jan 13, 2016 (2d) |
| Dec 10, 2015 | OPHT | ↓ Sell | 2,000 | $64.44 | $129K | Direct | Dec 14, 2015 (4d) |
| Dec 10, 2015 | OPHT | ↓ Sell | 1,000 | $64.44 | $64K | Indirect | Dec 14, 2015 (4d) |
| Nov 18, 2015 | OPHT | ↓ Sell | 1,000 | $60.00 | $60K | Direct | Nov 19, 2015 (1d) |
| Nov 18, 2015 | OPHT | ↓ Sell | 500 | $60.00 | $30K | Indirect | Nov 19, 2015 (1d) |
| Nov 10, 2015 | OPHT | ↓ Sell | 2,000 | $59.34 | $119K | Direct | Nov 12, 2015 (2d) |
| Nov 10, 2015 | OPHT | ↓ Sell | 1,000 | $59.34 | $59K | Indirect | Nov 12, 2015 (2d) |
| Nov 2, 2015 | OPHT | ↓ Sell | 1,000 | $54.00 | $54K | Direct | Nov 4, 2015 (2d) |
| Nov 2, 2015 | OPHT | ↓ Sell | 500 | $54.00 | $27K | Indirect | Nov 4, 2015 (2d) |
| Jun 30, 2015 | CATB | ↑ Buy | 376,695 | $12.00 | $4.5M | Indirect | Jun 30, 2015 (0d) |
| Jun 16, 2015 | OXFD | ↓ Sell | 41,230 | $14.30 | $590K | Direct | Jun 17, 2015 (1d) |
| Jun 12, 2015 | OXFD | ↓ Sell | 31,598 | $14.27 | $451K | Direct | Jun 12, 2015 (0d) |
| Jun 10, 2015 | OXFD | ↓ Sell | 24,649 | $14.28 | $352K | Direct | Jun 10, 2015 (0d) |
| Jun 3, 2015 | OXFD | ↓ Sell | 36,474 | $14.29 | $521K | Direct | Jun 3, 2015 (0d) |
| Mar 23, 2015 | OXFD | ↓ Sell | 53,415 | $14.49 | $774K | Direct | Mar 24, 2015 (1d) |
| Mar 19, 2015 | OXFD | ↓ Sell | 154,319 | $14.65 | $2.3M | Direct | Mar 19, 2015 (0d) |
| Jan 8, 2015 | AERI | ↓ Sell | 175,000 | $31.11 | $5.4M | Direct | Jan 12, 2015 (4d) |
| Jan 5, 2015 | AERI | ↓ Sell | 23,620 | $30.86 | $729K | Direct | Jan 6, 2015 (1d) |
| Dec 29, 2014 | AERI | ↓ Sell | 80,724 | $30.05 | $2.4M | Direct | Dec 30, 2014 (1d) |
| Dec 23, 2014 | AERI | ↓ Sell | 49,704 | $30.36 | $1.5M | Direct | Dec 24, 2014 (1d) |
| Jun 16, 2014 | OPHT | ↓ Sell | 144,976 | $44.17 | $6.4M | Indirect | Jun 16, 2014 (0d) |
| Jun 11, 2014 | OPHT | ↓ Sell | 211,180 | $45.42 | $9.6M | Direct | Jun 11, 2014 (0d) |
| Jun 11, 2014 | OPHT | ↓ Sell | 500 | $44.32 | $22K | Indirect | Jun 11, 2014 (0d) |
| Jun 10, 2014 | PTLA | ↓ Sell | 965 | $23.36 | $23K | Direct | Jun 11, 2014 (1d) |
| Jun 10, 2014 | PTLA | ↓ Sell | 404 | $23.36 | $9K | Indirect | Jun 11, 2014 (1d) |
| Dec 17, 2013 | TLOG | ↑ Buy | 1,425,063 | $7.00 | $10.0M | Direct | Dec 19, 2013 (2d) |
| Oct 25, 2013 | AERI | ↑ Buy | 321,000 | $10.00 | $3.2M | Direct | Oct 28, 2013 (3d) |
| Sep 30, 2013 | OPHT | ↑ Buy | 2,500 | $22.00 | $55K | Direct | Nov 20, 2013 (51d) |
| Sep 30, 2013 | OPHT | ↑ Buy | 2,500 | $22.00 | $55K | Indirect | Nov 20, 2013 (51d) |
| Aug 8, 2012 | GMED | ↓ Sell | 804,232 | $11.16 | $9.0M | By Fund | Aug 10, 2012 (2d) |
| Jul 9, 2012 | SOMX | ↓ Sell | 2,295,791 | $0.30 | $694K | Indirect | Jul 10, 2012 (1d) |
| Jul 3, 2012 | SOMX | ↓ Sell | 178,558 | $0.29 | $52K | Indirect | Jul 5, 2012 (2d) |
| Jun 28, 2012 | SOMX | ↓ Sell | 19,500 | $0.29 | $6K | Indirect | Jul 2, 2012 (4d) |
| Jun 19, 2012 | SOMX | ↓ Sell | 12,000 | $0.29 | $3K | Indirect | Jun 21, 2012 (2d) |
| Jun 15, 2012 | SOMX | ↓ Sell | 1,450 | $0.29 | $420 | Indirect | Jun 19, 2012 (4d) |
| Jun 6, 2012 | SOMX | ↓ Sell | 37,955 | $0.29 | $11K | Indirect | Jun 7, 2012 (1d) |
| May 31, 2012 | ACHN | ↓ Sell | 1,316,956 | $7.49 | $9.9M | By Fund | Jun 4, 2012 (4d) |
| May 31, 2012 | SOMX | ↓ Sell | 811,422 | $0.30 | $244K | Indirect | Jun 4, 2012 (4d) |
| Oct 27, 2011 | ZLCS | ↓ Sell | 738,807 | $1.03 | $761K | Indirect | Oct 28, 2011 (1d) |
| Oct 26, 2011 | ZLCS | ↓ Sell | 281,200 | $1.02 | $287K | Indirect | Oct 27, 2011 (1d) |
| Oct 24, 2011 | ZLCS | ↓ Sell | 322,100 | $1.03 | $331K | Indirect | Oct 25, 2011 (1d) |
| Oct 20, 2011 | ZLCS | ↓ Sell | 459,817 | $1.03 | $473K | Indirect | Oct 21, 2011 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Nicholas Galakatos's insider trades
Nicholas Galakatos is a director at Entasis Therapeutics Holdings (ETTX). Since Jun 20, 2005, Nicholas has reported 28 open-market purchases worth $100.4M and 76 sales worth $141.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
4 sales (2% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include other transactions (35 filings), grants and awards (27 filings), conversions (27 filings), option exercises (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ETTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.